Delivery Order SPE2DB24D6039-SPE2DB25FLEQF
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,325.66 by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Imiquimod 5% Cream in packets of 24 units. This is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,306.88 to AmerisourceBergen Drug Corp for Imiquimod 3.75% cream (28-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Imiquimod 3.75% cream (28 single-dose units) with a ceiling value of $1,625.09. This firm fixed-price delivery order, set to be completed by August 28, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made on a competitive basis with no set-aside designation, reflecting the contractor's established...
- This is a $1,560.19 firm fixed-price delivery order awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Imiquimod 5% Cream Packets, with a completion date of June 17, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, which provides a comprehensive global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,274.31 on August 21, 2025, with an ultimate completion date of August 22, 2025. The order is for Imiquimod 3.75% cream in 28-count units, a topical immunomodulatory medication used primarily for treating certain skin conditions. This non-set-aside, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- The Defense Logistics Agency Troop Support Medical awarded a $126,450 firm fixed price delivery order to Amerisourcebergen Drug Corporation for IMIQUIMOD 5% cream packets. The delivery order was issued against an undisclosed governmentwide acquisition contract vehicle or indefinite delivery/indefinite quantity contract held by Amerisourcebergen. Performance will take place in Conshohocken, Pennsylvania, spanning from July 31, 2023 through August 1, 2023. No set aside provisions or subcontractors...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,959.25, is for the delivery of IMIQUIMOD 5% cream packets. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of February 11, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Imiquimod 5% Cream Packets. The order has a ceiling value of $10,479.63 and is a firm fixed-price contract. The contract has an ultimate completion date of August 14, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and indefinite delivery contracts (IDCs) by the DLA and other agencies to provide a wide range of medical...
- The Defense Logistics Agency awarded a $403,050 delivery order to Amerisourcebergen Drug Corporation for IMIQUIMOD 5% cream packets. Under this firm fixed price contract, Amerisourcebergen will deliver 24 packets of the prescribed cream to a location in Conshohocken, Pennsylvania by August 4, 2023 to support the Department of Defense's medical supply needs. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the United...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of Imiquimod 3.75% Cream in 28-count packages. The contract has a potential value of $1,187.69 and a completion date of February 8, 2024. AmerisourceBergen Drug Corp is the sole prime contractor on this delivery order, which does not have a set-aside designation. The company also...
- SPE2DB24D6039Indefinite Delivery Contract
- SPE2DB24D6039-SPE2DB25FLEQFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,355.21 to AmerisourceBergen Drug Corp for Imiquimod 5% Cream in 24-packet units. This non-competitive, firm fixed-price delivery order was awarded on September 25, 2025, with an ultimate completion date of September 26, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. As a critical pharmaceutical distributor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies supporting military and veteran healthcare systems. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to fulfill diverse federal medical supply requirements across multiple therapeutic domains, making this specific delivery order one of numerous transactions executed under the broader agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/25/25 |